1. Mehndiratta, M. M., & Gulati, N. S. (2014). Central and peripheral demyelination. Journal of neurosciences in rural practice, 5(1), 84.
2. Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997). Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Annals of neurology, 42(5), 783-793.
3. Korn T. Pathophysiology of multiple sclerosis. Journal of neurology. 2008 Dec 1;255(6):2-6.
4. Carroll WM. 2017 McDonald MS diagnostic criteria: Evidence-based revisions.
5. Buck D, Hemmer B. Treatment of multiple sclerosis: current concepts and future perspectives. Journal of neurology. 2011 Oct 1;258(10):1747-62.
6. Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, De Seze J. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2013 Aug 1;84(8):922-30.
7. Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clinical & Experimental Immunology. 2014 May;176(2):149-64.
8. Wildemann B, Jarius S, Schwarz A, Diem R, Viehöver A, Hähnel S, Reindl M, Korporal-Kuhnke M. Failure of alemtuzumab therapy to control MOG encephalomyelitis. Neurology. 2017;89:207–9.
9. Jarius S, Paul F, Aktas O, Asgari N, Dale RC, De Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of neuroinflammation. 2018 Dec;15(1):134.
10. dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Frontiers in neurology. 2018 Apr 4;9:217.
11. Hartung HP. ADEM: distinct disease or part of the MS spectrum?. Neurology. 2001 May 22; 56 (10)
12. Kumar P, Kumar P, Sabharwal RK. Acute disseminated encephalomyelitis: Case report and brief review. Journal of family medicine and primary care. 2014 Oct;3(4):443.
13. Tillema JM, Pirko I. Neuroradiological evaluation of demyelinating disease. Therapeutic advances in neurological disorders. 2013 Jul;6(4):249-68.
14. Filippi, M., & Rocca, M. A. (2011). MR imaging of multiple sclerosis. Radiology, 259(3), 659-681.
15. Dutra BG, da Rocha AJ, Nunes RH, Maia AC. Neuromyelitis optica spectrum disorders: Spectrum of MR imaging findings and their differential diagnosis. Radiographics. 2018 Jan 10;38(1):169-93.
16. Vishnevskia-Dai V, Chapman J, Sheinfeld R, Sharon T, Huna-Baron R, Manor RS, Shoenfeld Y, Zloto O. Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis. Medicine. 2016 Oct;95(43).
17. Greco A, De Virgilio A, Gallo A, Fusconi M, Turchetta R, Tombolini M, Rizzo MI, De Vincentiis M. Susac's syndrome—pathogenesis, clinical variants and treatment approaches. Autoimmunity reviews. 2014 Aug 1;13(8):814-21.
18. Saenz R, Quan AW, Magalhaes A, Kish K. MRI of Susac's syndrome. American Journal of Roentgenology. 2005 May;184(5):1688-90.
19. Turkistani AN, Alshamrani FJ, Shareefi GF, Alsulaiman A. Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report. Electronic physician. 2018 Aug;10(8):7180.